Levothyroxine Shortage: What Providers and Prescribers Need to Know in 2026

Levothyroxine is among the most commonly prescribed medications in primary care and endocrinology practices across the United States. When supply issues arise — even localized ones — the clinical and administrative burden falls squarely on prescribers. This guide provides an up-to-date overview of the levothyroxine supply situation in 2026 and practical guidance for managing your thyroid patients through periods of constrained availability.

Current Availability Status (2026)

As of 2026, the FDA's official drug shortage database does not list generic levothyroxine oral tablets. However, real-world availability is uneven:

Generic levothyroxine tablets: Common strengths (25-125 mcg) are broadly available. Less common strengths — particularly 137, 175, 200, and 300 mcg — continue to be intermittently unavailable at chain pharmacies.

Synthroid: AbbVie's Synthroid is broadly available; the Synthroid Delivers direct-mail program provides a reliable supply channel at $75 per 90-day supply.

Levoxyl: Pfizer continues to manufacture Levoxyl, but market share is low and many chain pharmacies (CVS, Walgreens, Rite Aid) do not stock it routinely. Independent pharmacies and mail-order options are more reliable for brand-dependent patients.

Tirosint: Generally available; less impacted by generic shortage dynamics.

IV injection: Levothyroxine sodium injection (used for myxedema coma) has an active ASHP shortage listing (Sagent 500 mcg vial). Fresenius Kabi, Par, and Sagent have supply of other presentations available.

Clinical Context: Why Levothyroxine Switching Is Complex

The American Thyroid Association (ATA), the Endocrine Society, and the American Association of Clinical Endocrinologists (AACE) have issued guidance cautioning against routine substitution between levothyroxine products without monitoring. Key points:

Levothyroxine has a narrow therapeutic index. FDA bioequivalence standards allow 80-125% potency range for levothyroxine, which can result in clinically meaningful TSH shifts when products change.

AB-rated generic products are NOT necessarily interchangeable in sensitive populations (congenital hypothyroidism, thyroid cancer patients on TSH suppression, pregnant patients).

Brand switching in patients who were previously stable should be followed by a TSH check 6-8 weeks after the switch.

Brand Switching Protocols

When switching is necessary, use the following conversion guidelines:

Generic → Synthroid: 1:1 microgram conversion (e.g., 100 mcg generic → 100 mcg Synthroid). Recheck TSH in 6-8 weeks.

Generic → Tirosint: 1:1 conversion. Tirosint's superior absorption may result in TSH dropping below target; monitor and be prepared to reduce dose if needed.

Levothyroxine → Armour Thyroid (if available): Complex conversion. Approximately 60 mg (1 grain) Armour Thyroid ≈ 88-100 mcg levothyroxine. Not recommended as a primary shortage strategy given Armour Thyroid's own supply uncertainty and FDA enforcement action.

High-Risk Patients Who Need Priority Attention

Prioritize these patient groups if supply is constrained:

Post-thyroidectomy patients — No endogenous production; dependent on exogenous T4 for survival

Thyroid cancer patients on TSH suppression — TSH suppression is part of the treatment protocol; inadequate dosing may allow tumor regrowth

Pregnant patients — Levothyroxine requirements increase during pregnancy; inadequate dosing is associated with impaired fetal neurodevelopment

Neonates with congenital hypothyroidism — Critical for normal cognitive and physical development; cannot miss doses

Tools to Help Your Patients Find Levothyroxine

medfinder is a pharmacy availability search service that calls pharmacies on behalf of patients to identify which ones have their specific levothyroxine strength in stock. You can direct patients to medfinder's provider page or recommend the service directly. It eliminates the patient burden of calling multiple pharmacies and reduces callbacks to your office.

Savings Resources for Patients Who Can't Afford Their Levothyroxine

Generic levothyroxine: GoodRx coupons bring the price to as low as $9.90 for most strengths. Walmart and Amazon Pharmacy offer $4/month or $10/90-day supply.

Synthroid co-pay card: Commercially insured patients can pay as little as $25/month. Not available for Medicare/Medicaid patients.

AbbVie myAbbVie Assist: Patient Assistance Foundation for qualifying uninsured or underinsured patients. Application requires physician participation.

Synthroid Delivers Program: Cash-pay direct delivery at $75/90-day supply; no insurance needed; consistent brand-name supply.

For a practical workflow guide, see how to help your patients find levothyroxine in stock.